The leak provides competitors—from established giants to nimble rivals like Cursor—a literal blueprint for how to build a ...
China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results